Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
BMC Ophthalmology|December 23, 2009
Evaluation of a new disposable silicon limbal relaxing incision knife by experienced usersJohn Albanese, Geoffrey Dugue, Valentin Parvu, et al.Gynecologic Oncology|May 7, 2023
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trialMark H Stoler, Valentin Parvu, Karen Yanson, et al.Microbiology Spectrum|September 12, 2025
Improved time-to-detection with the new formulation of BD BACTEC Plus Aerobic/F Culture Vials: a real-world evidence studyKayla Van Benten, Mondraya Howard, Valentin Parvu, et al.Journal of Biopharmaceutical Statistics|June 1, 2022
A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studiesGraeme L Hickey, Valentin Parvu, Yongqiang Zhang, et al.Gynecologic Oncology Reports|June 17, 2024
Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screeningLaurence Vaughan, Devin Gary, Millie Shah, et al.Journal of Clinical Microbiology|September 5, 2025
Enhancing blood culture volume with ultrathin-wall cannula devicesGrant Johnson, Valentin Parvu, Stephane Beauchamp, et al.Gynecologic Oncology|June 5, 2019
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytologyThomas C Wright, Mark H Stoler, Valentin Parvu, et al.Frontiers in Public Health|April 22, 2022
Large-Scale SARS-CoV-2 Antigen Testing With Real-World SpecimensAshish Parikh, Lauren Cooper, Daniel Frogel, et al.Gynecologic Oncology|March 5, 2026
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assayDidier Morel, Valentin Parvu, Jeffrey Andrews, et al.Gynecologic Oncology|January 15, 2019
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytologyMark H Stoler, Thomas C Wright, Valentin Parvu, et al.Pageof 3